The FDA's April 1 statement directly addressed this practice, clarifying that adding an ingredient does not automatically exempt a compound from the "essentially a copy" standard
Are oral weight loss medications coming soon
Journal of Clinical Pharmacy and Therapeutics, 47 (2), 184193
Program integration began in January 2026 with these early results pointing to a huge savings opportunity for other organizations grappling with runaway anti-obesity medication expenses
Always consult with a qualified healthcare provider before starting, stopping, or changing any medication
FDA Status and What You Need to Know in 2026 Current FDA regulatory status of BPC-157, sermorelin, CJC-1295, and other peptides used in anti-aging medicine